A Next Generation of Pneumococcal Disease Protection

Upon completion of this activity, participants should be able to:

• Explain the rationale behind the development of next generation pneumococcal conjugate vaccines
• Identify highest-risk groups who should receive PCV15 versus PCV20
• Formulate strategies to engage patients in shared clinical decision-making per CDC recommendations